谷歌浏览器插件
订阅小程序
在清言上使用

Figure S1: Doses Given and DLTs Experienced in the Dose Escalation and Dose Expansion Cohorts from A First-in-Human Study of the New Oral Selective Estrogen Receptor Degrader AZD9496 for ER+/HER2− Advanced Breast Cancer

openalex(2023)

引用 0|浏览1
关键词
Alpha Particle Therapy,Neoadjuvant Therapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要